Showing 102 news articles about PrEP science

Filters Content type: Editors' picks Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

The search for an HIV prevention vaccine

A trial is underway that could be ‘the last roll of the dice’ for an HIV vaccine this decade

Editor's pick
CNN
28 August 2023
PrEP science

Adherence Support Needed for MSM Choosing On-Demand PrEP, West African Study Reports

Editor's pick
TheBodyPro
5 June 2023
PrEP science

Oral PrEP Is Effective for Women, but Only if They Take it Consistently

Editor's pick
POZ
23 May 2023
The search for an HIV prevention vaccine

It’s Time to End AIDS: Why EU Should Fund Search for HIV Vaccine

Editor's pick
Health Policy Watch
19 May 2023
Injectable & long-acting PrEP

Large Benefit With Long-Acting PrEP in Black People, but Some HIV Risk Persists

Editor's pick
MedPage Today
22 February 2023
PrEP programmes & uptake

Preexposure Prophylaxis Gives Good Results in Latin America

Editor's pick
Medscape (requires free registration)
23 January 2023
PrEP science

For Patients Taking PrEP, Poor Adherence Drives HIV Seroconversions

Editor's pick
Physician's Weekly
5 October 2022
New & experimental HIV treatments

Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection

Editor's pick
Merck press release
20 September 2022
PrEP science

On-Demand PrEP Works as Well as Daily Pills

Editor's pick
POZ
13 July 2022
PrEP policies & guidelines

PrEP Can Be Cost-Effective in Sub-Saharan Africa

Editor's pick
Contagion Live
16 May 2022
PrEP science

Long-acting doravirine implants as PrEP to prevent vaginal HIV transmission in mouse study

Editor's pick
i-Base
24 February 2022
Drug interactions & pharmacokinetics

No Interactions Between Hormone Therapy and PrEP in Transgender Women or Men

Editor's pick
NATAP
24 February 2022
PrEP science

Landscape report launched on novel technologies for the prevention of HIV, STIs, and unwanted pregnancy

Editor's pick
Unitaid
10 December 2021
Adherence

Digital pill tracks HIV prevention pill adherence with 98 percent accuracy

Editor's pick
European Pharmaceutical Review
9 December 2021
Pharmaceutical industry

Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multi-pronged R&D strategy

Editor's pick
FierceBiotech
7 December 2021
PrEP science

Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection

Editor's pick
BusinessWire
7 December 2021
PrEP science

Kidney Toxicity Rare With Daily or On-Demand (As-Needed) PrEP

Editor's pick
NATAP
31 October 2021
PrEP science

Islatravir Subdermal Implant for HIV PrEP Has Promising Phase 1 Trial

Editor's pick
Contagion Live
7 October 2021
PrEP science

First-in-Class NRTTI Demonstrates Potential as Long-Acting Oral PrEP Against HIV

Editor's pick
Contagion Live
13 September 2021
PrEP science

Truvada or Descovy for PrEP? Your Lab Work May Tell You

Editor's pick
POZ
8 September 2021
Resistance

Transmitted Drug Resistance to Tenofovir and Emtricitabine is declining in China

Editor's pick
Infectious Disease Advisor
12 August 2021
PrEP science

Two PrEP medications are now available. Equally safe/effective. The biggest difference? The price tag.

Editor's pick
Medical Xpress
5 August 2021
Coronavirus

PrEP Study Sees No Link Between Tenofovir and COVID-19

Editor's pick
POZ
28 July 2021
Injectable & long-acting PrEP

IAS: Merck's long-acting HIV med hits protective levels in phase 2

Editor's pick
FierceBiotech
21 July 2021